Health
Tech

Wearables & Fitness Trackers

The wearable market is built on a clever sleight of hand: it sells you precision while delivering trends. That's not a scam — trends are genuinely useful — but it's worth knowing which is which. Optical heart rate sensors (the green lights on the back of your watch or ring) are accurate at rest and during steady-state activity, with validation studies showing mean absolute percentage error under 10%.[1] During interval training, where the wrist moves abruptly, accuracy falls. And while earlier reports raised concerns that the green-light technology reads less accurately on darker skin, a 2020 study across a range of skin tones found accuracy varied mainly by activity, not skin colour.[2] These are not reasons to avoid wearables — they're reasons to interpret the numbers correctly.

The real decision between devices is rarely about which sensor is "best." It's about which trade-off matches your life: a ring for unobtrusive 24/7 sleep tracking, a full smartwatch for active features and notifications, or a dedicated training watch for GPS depth. And critically, the true cost isn't the sticker price — it's the three-year cost including subscriptions, which is where devices like WHOOP and the Apple Watch diverge dramatically. Our comparisons run that math so you don't get surprised at month 13.

• → Oura Ring vs Apple Watch: Which Wearable Matches Your Goals? — sleep, HRV accuracy, women's health, battery, and real 24-month cost
• → WHOOP vs Apple Watch: Which Fitness Wearable Improves Your Health? — recovery scoring, sleep coaching, and the $959 vs $249 three-year cost gap
• → Fitbit vs Garmin: Which Fitness Tracker Is Worth It in 2026? — GPS accuracy, sleep tracking, battery, and long-term health metrics

Find the Right Wearable for You

The hardest part of buying a wearable isn't the money — it's that every device is marketed as the best one for everyone, which is statistically impossible. The right device depends on what you'll actually use: do you care most about sleep, recovery, GPS training data, women's health metrics, battery life, or smartwatch features? Ranking those priorities is the whole decision, and it's different for every person. A serious marathoner and someone tracking perimenopausal sleep disruption should not buy the same device, even though the marketing aims both at the same checkout page.

The Health Wearable Finder asks six questions, weights your answers across ten metrics, and matches you to one of five devices — Oura Ring, WHOOP, Apple Watch, Garmin Fenix, or Fitbit Sense — with a full spec comparison so you can see why. It's the fastest way to skip the review-reading and get to a shortlist that fits your actual priorities.

• → Health Wearable Finder — 6 questions, 10 metrics, 5 devices, with a full spec comparison table

Continuous Glucose Monitors (CGMs)

Continuous glucose monitoring used to require a diabetes diagnosis and a prescription. That changed in March 2024, when the FDA cleared Dexcom's Stelo as the first over-the-counter glucose biosensor, followed by Abbott's Lingo.[3] A small sensor on your arm now streams real-time glucose data to your phone, showing how a particular meal, a stressful meeting, or a poor night's sleep moves your blood sugar. For people with diabetes or prediabetes, this is genuinely valuable, clinically supported technology.

For metabolically healthy people, the picture is more honest than the marketing suggests. There is currently no strong evidence that CGM use improves health outcomes in non-diabetics. The data can build awareness — and awareness can motivate better choices — but a glucose spike after eating is a normal physiological response, not a problem to be eliminated. For some users, watching every fluctuation creates anxiety rather than insight. A CGM is a measurement tool, not a treatment. If you're curious about your metabolic response and willing to interpret the data calmly, it can be informative. Just don't expect a sensor to do what a sustained change in diet and activity does. You can't fix a poisoned lake by buying a better water-quality meter.

• → In-depth CGM-for-non-diabetics reviews (Stelo, Lingo, Levels) are in development. Subscribe below to be notified.
• → Related: Metabolic Health Test — what blood markers matter — from the Metabolic Health hub

GLP-1 Access, Cost & Safety

GLP-1 medications are the most in-demand metabolic drugs in a generation, and demand at those prices has created an entire ecosystem around access — some of it legitimate, some of it genuinely risky. Wegovy's retail price is roughly $1,349 a month, which is why most of the real-world action is in finding legal, lower-cost routes: licensed telehealth platforms, manufacturer savings programs, compounded options where permitted, and insurance or Medicare coverage. These exist and most patients never explore all of them.

Then there's the grey market. "Research peptide" vendors sell GLP-1 compounds online for a fraction of the price, labelled "research use only" specifically to sidestep the FDA approval process. These products are not manufactured to pharmaceutical standards, independent testing has found inconsistent purity and dosing, and self-administering them carries real safety and legal risk. WiseGoodness covers this category so you understand what's actually being sold — not as an endorsement. The honest recommendation is the legitimate route, through a clinician. For comparison shoppers weighing older options, we also break down how GLP-1 drugs differ mechanistically from a stimulant like phentermine, which explains the large gap in results.

• → Cheapest Ways to Get GLP-1 in 2026 — From $25/Month to Telehealth — seven legitimate routes most patients never explore
• → Phentermine vs GLP-1: What's the Difference? — 1959 stimulant (5–9% loss) vs hormone-based class (14–21%); the mechanism gap
• → GLP-1 Peptides for Sale: What to Know Before Buying — what "research use only" means legally and what independent testing found [grey-market category — not FDA-approved for human use; we advise the legitimate route via a clinician]

AI Diagnostics & Digital Health

Artificial intelligence in healthcare is simultaneously the most over-hyped and most genuinely promising category in health tech. The promise is real: machine learning models have demonstrated physician-level accuracy in narrow tasks like detecting diabetic retinopathy from retinal scans, flagging certain cancers on imaging, and identifying atrial fibrillation from ECG data. These are specific, validated, regulated use cases — not the "AI will replace your doctor" headline.

The hype is everywhere else: symptom-checker apps that confidently misdiagnose, "AI-powered" wellness products whose intelligence is a marketing adjective, and direct-to-consumer tools that generate impressive-looking output with no validation behind it. The distinction that matters is whether a tool has been clinically validated for the specific thing it claims to do, and whether it's regulated as a medical device or sold as "wellness" to avoid that scrutiny. We'll cover this category — telemedicine outcomes, AI diagnostics, and digital health tools — with the same evidence-first lens applied to wearables: what's validated, what's marketing, and how to tell them apart.

• → In-depth articles on AI diagnostics, telemedicine, and digital health tools are in development. Subscribe below to be notified.

Where to Start

If you're new to this hub, three questions point you to the right starting place:

Frequently Asked Questions